An interventional study of custom-created apps, neuropsychological testing, and clinical assessments in Patient Discharge, Neurocognition and Baseline, sponsored by University of Illinois at Chicago. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.
University of Illinois at Chicago is the lead sponsor of 496 studies on the registry; 115 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Diagnostic Test: custom-created apps, neuropsychological testing, and clinical assessments
This study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment. Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint
Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ
comparison of results to baseline measurements of these four validated neuropsychiatric assessments
Time frame: 24 hours
Memory App
Use of a colored sequence presentation memory app to assess subjects return to baseline
Time frame: 24 hours
Flight Path App
Seated subject follows the flight path of a bird on an iPad app. Comparisons made to baseline performance.
Time frame: 24 hours
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Apr 2031, 53 months later.
Start moved once since we started tracking on Sep 25, 2026: May 2026 → Oct 2026, on Oct 9, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Illinois at Chicago →